Cabazitaxel Plus Lapatinib as Therapy for HER2+ Metastatic Breast Cancer With Intracranial Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Breast Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cabazitaxel Plus Lapatinib as Therapy for HER2+ Metastatic Breast Cancer With Intracranial Metastases: Results of a Dose-Finding Study
Clin. Breast Cancer 2018 Mar 08;[EPub Ahead of Print], DA Yardley, LL Hart, PJ Ward, GL Wright, M Shastry, L Finney, LM DeBusk, JD HainsworthFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.